Processa Pharmaceuticals Inc. (PCSA)
NASDAQ · Healthcare
Processa Pharmaceuticals Inc. Operating Income 2012–2022
Processa Pharmaceuticals Inc. annual/quarterly operating income history and growth rate from 2016 to 2023. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Processa Pharmaceuticals Inc. operating income for the quarter ending March 31, 2023 was -4.1 M, a 27.16% increase year-over-year.
- Processa Pharmaceuticals Inc. annual operating income for 2022 was -27.5 M, a 126.85% increase from 2021.
- Processa Pharmaceuticals Inc. annual operating income for 2021 was -12.1 M, a 531.46% increase from 2016.
- Processa Pharmaceuticals Inc. annual operating income for 2016 was -1.9 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Processa Pharmaceuticals Inc. Operating Income — FAQ
Processa Pharmaceuticals Inc. (PCSA) operating income over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
What is Processa Pharmaceuticals Inc.'s operating income?
Processa Pharmaceuticals Inc. (PCSA) reported operating income of -$28M for fiscal 2022.
Where can I see PCSA's operating income history?
The chart and table above show Processa Pharmaceuticals Inc.'s operating income by year and by quarter, including the growth rate.